Colpermin

Quick links to important sections

Colpermin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Colpermin

Colpermin is an oral herbal medicinal product containing a single active ingredient, Peppermint Oil (Mentha piperita essential oil). It is categorized as an antispasmodic agent, a type of medicine specifically designed to relieve painful, involuntary spasms in the digestive tract. The medicine is typically sold Over-The-Counter (OTC).

Property Description
Active Ingredient Peppermint Oil (Mentha piperita essential oil)
Form Gastro-resistant capsules (Enteric-coated capsules)
Pharmacological Class Antispasmodic agent
Common Use Symptomatic relief of minor digestive spasms and flatulence
Origin Herbal/Natural (Derived from the Mentha piperita plant)

Definition and Core Pharmaceutical Class

This medicine is formally recognized as a monocomponent drug based on its active agent being a distilled essential oil. Its pharmacological role is the symptomatic relief of minor spasms of the gastrointestinal tract and flatulence. This classification confirms the medicine's role in easing digestive discomfort.

The Composition and Purpose of the Gastro-Resistant Capsule

The therapeutic effect of the oil is largely attributed to its main constituent, Menthol. The oil itself is delivered in a specialized dosage form: an oral gastro-resistant capsule. This is a key differentiating feature, as this enteric-coated design ensures that the Peppermint Oil is not released in the stomach, which could cause local irritation. Instead, the coating ensures that the oil is delivered intact to the lower intestine. This targeted delivery allows the concentrated oil to exert its local effect precisely where painful intestinal spasms and bloating often originate. The constituent Menthol produces a relaxing effect on the gastrointestinal tract.

The Primary Mechanism: Smooth Muscle Relaxation

Colpermin’s general benefit is achieved by inducing smooth muscle relaxation within the intestinal wall. This action is the primary function of the active Menthol component. By directly countering the involuntary, painful contractions of the gut and possessing a carminative property (assisting in the passage of gas), the medicine’s core purpose is to ease internal pressure and alleviate generalized cramping discomfort.

Regulatory References

  1. EMA Menthae piperitae aetheroleum Summary
  2. EMA Monograph on Peppermint Oil

What side effects are possible with Colpermin?

Possible Side Effects and Safety Information

The information below summarizes the officially documented adverse effects and safety constraints for Peppermint Oil gastro-resistant capsules, as outlined in government regulatory documents.


Documented Adverse Reactions

The majority of side effects are classified with a frequency of 'Not known', meaning the rate cannot be reliably estimated from available data, typically derived from post-marketing reports. The most frequently cited adverse reactions involve the Gastrointestinal System and Immune System.

System Organ Class Common Adverse Reactions (Not Known Frequency)
Gastrointestinal Disorders Gastrooesophageal reflux (Heartburn), Nausea, Vomiting, Dyspepsia, Anorectal discomfort.
Immune System Disorders Hypersensitivity reactions, including skin rash, headache, and joint pain.
Nervous System Disorders Headache, Muscle tremor, Ataxia (impaired coordination).

Serious Safety Considerations and Restrictions

Official documents list several serious adverse events that have been reported:

  • Serious Reactions: Documented serious events include Anaphylactic shock (a severe allergic reaction), Gastric haemorrhage (stomach bleeding), and Bradycardia (slowed heart rate).

  • Population Restrictions: The medicine is contraindicated for use in children under 8 years of age. Use is not recommended during pregnancy or lactation due to insufficient safety data.

  • Contraindicated Conditions: The product must not be used by individuals with certain underlying health issues, including known liver disease, gallstones, biliary disorders, cholangitis, or achlorhydria (absence of stomach acid). The product is also contraindicated for those with allergies to Peppermint Oil, menthol, arachis oil (peanut oil), or soya.

  • Co-Exposure Notes: The label notes that Central Nervous System effects, such as tremor and ataxia, have been reported in conjunction with alcohol consumption.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for the active ingredient in Colpermin, Peppermint Oil, is defined by severe symptoms across multiple physiological systems. Documented manifestations of overdose include pronounced gastrointestinal distress, such as severe nausea, vomiting, and abdominal pain. More serious clinical signs involve the central nervous system, where overdose may cause symptoms ranging from vertigo, drowsiness, and ataxia (uncoordinated movement) to severe depression, convulsions, and progression to coma.

Regulators mandate that individuals must seek medical help right away and contact a Poison Control Center or the local emergency number immediately if an overdose is suspected. This immediate action is required due to the potential for life-threatening outcomes, which can include changes in heart function (e.g., slow heartbeat) and complications like loss of urine production.

Management procedures officially described in prescribing information focus on supportive and symptomatic treatment. These measures include emptying the stomach via gastric lavage and providing breathing support if warranted. Hospital monitoring is required, involving the measurement of vital signs and diagnostic tests, such as an Electrocardiogram (ECG), and blood and urine tests, to assess the systemic effect. No specific antidote is formally documented.

Therapeutic Uses of Colpermin

What Colpermin Treats: Main Uses and Benefits

This product is commonly applied in clinical settings that involve acute or unstable symptom patterns. It is relevant in contexts marked by increased discomfort, specifically for the symptomatic relief of minor spasms of the gastrointestinal tract and flatulence associated with conditions like Irritable Bowel Syndrome (IBS).


Key Symptom Relief and Therapeutic Support

This medicine is commonly used across conditions characterized by periods of heightened symptoms, such as IBS, where it may be part of symptomatic management during phases when symptoms become more noticeable. It helps address symptom clusters that may become intense or disruptive, including painful intestinal spasms, abdominal cramping, bloating, and trapped wind. The medication supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load, which is the primary patient benefit. It is generally used when short-term symptomatic assistance is appropriate, often applied in scenarios where additional management of discomfort is required.


Quick Fact: Relief for Functional Symptoms
Colpermin supports patients by providing supportive symptomatic relief for spasm-driven pain and gas-related discomfort typical of IBS.

Eligibility and Restrictions for Use

Official Eligibility for Colpermin (Peppermint Oil)

Eligibility to use Colpermin is strictly defined by regulatory labeling and excludes several population groups and clinical conditions.

Contraindications and Non-Eligibility

Category Non-Eligible Populations or Conditions
Absolute Contraindications Hypersensitivity to peppermint oil, menthol, or excipients, including peanut oil (arachis) and soya.
Achlorhydria (absence of stomach acid).
Patients with gallstones, biliary strictures, cholecystitis, or other known liver disease.
Age Restriction Children under 15 years (or under 8 years, depending on the specific product label) are generally contraindicated or not recommended due to a lack of established safety data.
Reproductive Status Pregnant women, breastfeeding women, and women of childbearing potential not using effective contraception are not recommended to use this medicine due to insufficient clinical data.

Conditional Use

Patients who already suffer from heartburn should use caution, and treatment must be discontinued if these symptoms worsen after taking Colpermin.

What should I know about interactions with other medicines?

The official regulatory interaction profile for this medicine is primarily defined by the specific requirements of its gastro-resistant capsule formulation, classifying the most significant documented interactions as administration-timing constraints. Systemic drug-drug interaction studies are not typically included in the official labeling, as the medicine's action is intended to be local to the intestine.

Administration-Timing Interactions

The most important documented interaction pattern involves substances that reduce stomach acidity. These medicines may cause the premature dissolution of the capsule's enteric coating, leading to the Peppermint Oil being released in the stomach instead of the lower bowel. The outcome of this interaction is a reduction in effective exposure at the target site and potential local gastric irritation.

Interacting Substance Class Administration Constraint
Acid-Reducing Agents (Antacids, PPIs, H2-Blockers) Must be administered at least two hours before or two hours after the capsule.
Food The capsule must not be taken immediately after a meal.

Substance-Related Interaction

Official labeling indicates that the consumption of alcohol may increase the risk of specific, documented systemic side effects, including bradycardia (slow heart rate), muscle tremor, and ataxia. This represents a documented substance-related interaction that warrants caution.

Mechanism of Action

How Colpermin Works

Colpermin (peppermint oil) works through a direct, localized pharmacodynamic action on the gastrointestinal tract. The specialized enteric coating ensures that the active ingredient, menthol, is released only in the distal small intestine and colon, targeting the smooth muscle and afferent sensory nerves.

Direct Smooth Muscle Relaxation (Antispasmodic Effect)

Menthol acts as a calcium channel modulator on the smooth muscle cells of the intestinal wall. This interaction inhibits the influx of Ca^2+ ions required for muscular contraction. This mechanistic cascade leads to a reduction in smooth muscle tone, resulting in decreased depolarization frequency and a reduction in involuntary contractile events.

Modulation of Visceral Signaling

Menthol also influences the afferent neural pathways in the gut lining. By locally modulating the sensitivity of these sensory nerves, the drug influences the transmission kinetics of localized intraluminal sensory signals. This action modifies the response threshold to afferent neural input within the enteric nervous system.

Dosage and Administration Information

How Colpermin is Used: Official Administration Guidelines

This section outlines the instructions for the use of Colpermin gastro-resistant capsules. These instructions define the standardized procedure for administration.


Official Dosing and Frequency

Colpermin is an oral product containing 187 mg of Peppermint Oil per capsule, which is the route and strength defined for this medicine. The standard daily regimen is structured as follows:

Patient Group Starting Dose Maximum Dose (if required) Frequency
Adults and Adolescents (15+ years) One capsule Two capsules Three times a day (TID)

These dosing rules characterize the standard use of the medicine.

Administration Requirements

The specialized gastro-resistant coating of the capsule mandates precise administration to ensure the Peppermint Oil reaches the lower intestine intact, avoiding irritation in the stomach. The official procedural rules include:

  • Method: Capsules must be swallowed whole (not chewed, broken, or crushed) and taken with a small quantity of water.
  • Timing: The medicine should be taken 30 to 60 minutes before food (meals) and must not be taken immediately after eating.
  • Antacids: Administration should be separated from antacids or other indigestion remedies to prevent potential dissolution of the enteric coating.

Duration and Specific Populations

Treatment duration is typically short, usually continuing until symptoms resolve, generally within one or two weeks. If symptoms persist, the treatment course may be extended for periods not exceeding 2 to 3 months per course. Use in children under 15 years is officially not recommended due to insufficient data on efficacy and safety in this age group.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Colpermin

Research on Peppermint Oil, the active component in Colpermin, was studied for its use in managing symptoms related to the digestive tract. Clinical studies are primarily designed to explore how this oral herbal product was evaluated in comparison to inactive treatments (placebo) over short periods, utilizing Randomized Controlled Trials (RCTs) and systematic reviews.


Evidence for Use in Irritable Bowel Syndrome (IBS)

The clinical evaluation for the use of this product in adults with Irritable Bowel Syndrome (IBS) involved numerous RCTs. These studies were designed to measure changes in abdominal pain frequency and severity and patient-reported discomfort. Studies described patterns observed where proportions of subjects with a defined measured change in global symptom outcomes were compared to those receiving placebo. The European Medicines Agency (EMA) has published monographs describing the criteria for its use for minor spasms and flatulence as "well-established" based on available scientific literature.


Evidence in Pediatric Patients with Functional Abdominal Pain

Research has also explored the product's use in children and adolescents dealing with Functional Abdominal Pain (FAP) or IBS. These trials monitored specific outcomes related to abdominal pain intensity and frequency. However, certainty remains low for general use in this age group, as there is a limited number of high-quality clinical trials and existing studies often have modest sample sizes.


Long-Term Studies, Special Populations, and Uncertainty

The clinical research primarily reflects short-term symptom changes with follow-up durations typically limited to between four and eight weeks. This means there is limited information for long-term outcomes or how the effects are sustained over many months. Uncertainty also lies in the consistency of findings, as certain rigorous individual trials have reported mixed findings for regulatory endpoints. Data for other special populations, such as older adults or pregnant individuals, remains insufficient in dedicated clinical trials.

Key Studies & References

  1. Irritable bowel syndrome in adults: diagnosis and management (NICE Guideline NG12)

Frequently Asked Questions (FAQ)

Common questions about Colpermin (FAQ)


Q: What is the difference between Colpermin and other peppermint oil capsules for IBS?

Official documents describe Colpermin as a specialized gastro-resistant capsule containing 187 mg of peppermint oil. This design is key because the specialized coating is intended to prevent the premature release of the oil in the stomach, ensuring it travels intact to the lower intestine where it can act locally.


Q: How long does Colpermin usually take to start working?

According to the official product information, the capsule is designed to be gastro-resistant, which means the active ingredient's release is delayed until the capsule reaches the lower intestine. Because of this localized release mechanism, symptomatic relief is generally not instantaneous.


Q: Can Colpermin interact with medicines that reduce stomach acid, like antacids or PPIs?

Regulatory labeling specifies that acid-lowering medications, such as antacids, proton pump inhibitors (PPIs), and H2-receptor antagonists, should not be taken at the same time as Colpermin. Regulatory labeling specifies that taking these medicines together may lead to the premature dissolution of the capsule's coating, which is why separation is recommended.


Q: Does Colpermin affect the effectiveness of other medications like blood pressure drugs?

Official documents note that the medicine's therapeutic action is primarily local to the gastrointestinal tract, rather than systemic (affecting the entire body). For this reason, the principal documented interactions relate to protecting the capsule's coating integrity, not affecting the systemic efficacy of other drugs like blood pressure medications.


Q: Can Colpermin cause anal irritation or a burning sensation around the rectum?

Regulatory safety information lists anorectal discomfort as a potential adverse reaction. This adverse event is categorized as 'Anorectal discomfort' in the regulatory safety information.


Q: What does the term 'sustained release' mean in relation to Colpermin capsules?

Official product characteristics describe the capsule as sustained release enteric coated. This means the formulation is designed to delay the release of the peppermint oil until the lower bowel is reached, where the oil is then released slowly over time.


Q: Are the effects of Colpermin immediate or cumulative over several days?

The action is based on a delayed release formulation. Official use is defined by short treatment periods, typically limited to one or two weeks. This duration, combined with the delayed-release mechanism, suggests that relief is not expected to be instantaneous.


Q: Can Colpermin be used 'as needed' or does it need to be taken daily?

The recommended dosing schedule, as defined in the regulatory documentation, is a structured daily regimen. This means the medicine is typically taken a specified number of times throughout the day.


Q: Is Colpermin a natural product or a pharmaceutical medicine?

Official documents classify Colpermin as an oral herbal medicinal product containing Peppermint Oil. It is derived from the Mentha piperita plant.


Q: Should a person consult a doctor if their IBS symptoms change while using Colpermin?

Regulatory labeling indicates that consultation with a doctor is a precaution for specific situations. These include if IBS symptoms have recently changed, or if a person experiences other symptoms such as unexplained weight loss, loss of appetite, or vomiting.


Q: Can Colpermin cause dry mouth as a side effect?

Dry mouth is listed as one of the possible adverse effects found in the medicine's regulatory safety documentation.


Q: Can Colpermin be used for general stomach pain that is not related to IBS?

The official indication, as defined by regulatory authorities, is for the symptomatic relief of minor spasms and flatulence, typically associated with Irritable Bowel Syndrome (IBS).


Q: Is there a link between taking Colpermin and experiencing nausea or vomiting?

Regulatory safety information documents that nausea and vomiting are listed among the potential adverse reactions associated with the use of the medicine.


Q: What should a person do if they forget to take a capsule?

Regulatory instructions for a missed dose describe that taking the capsule as soon as it is remembered is the usual approach. However, if it is nearly time for the next scheduled dose, the direction is that the missed dose should be skipped.


Q: Do I need to see a doctor before starting to take Colpermin?

The product labeling indicates that consultation with a doctor is a precaution for specific situations. This includes when symptoms first appear, or if a patient is over 40 and their symptoms have changed.


Q: Is Colpermin the same as taking a digestive aid or a probiotic?

Colpermin is classified by regulators as an oral herbal medicinal product and is categorized as an antispasmodic agent. This classification and function differ from those of digestive aids or probiotics.


Q: Do the ingredients in Colpermin contain gelatin?

Official excipient lists, which detail the capsule’s non-active components, confirm that the capsule shell contains gelatin.


Q: Can Colpermin cause a rash or other signs of an allergic reaction?

The safety information documents potential Hypersensitivity reactions, which may include a skin rash. It also notes that anaphylactic shock is a documented serious adverse event.


Q: Is Colpermin used to treat symptoms besides those related to IBS?

The official indication provided by regulatory authorities is for the symptomatic relief of minor spasms of the gastrointestinal tract and flatulence.

How should Colpermin be stored and disposed of?

Colpermin must be stored and disposed of according to specific regulatory requirements to maintain its stability and ensure safety.

Official Storage Conditions

The medicine requires defined storage conditions to protect its integrity throughout the shelf life:

  • Temperature: Store below 25 C. The product should not be stored above this temperature.
  • Protection: The capsules must be kept in their original packaging to shield them from exposure to both light and moisture.
  • Safety: The product must be stored out of the sight and reach of children to prevent accidental ingestion.

Handling and Disposal

The official labeling mandates that Colpermin must not be used after the expiry date printed on the carton. Any unused or expired medicine, as well as waste material, must be disposed of in accordance with local requirements for pharmaceutical waste, often involving return to a pharmacy or municipal scheme.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Colpermin found in:

A-Z Index: